Aurobindo Pharma Limited
AUROPHARMA
Rangering i aksjer
#2074
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Aksjekurs
$17.34
Markedsverdi
$9.98B
Endring (1 dag)
-3.08%
Endring (1 år)
38.71%
Land
IN
Handel Aurobindo Pharma Limited (AUROPHARMA)
Kategori
Healthcare
Antall utestående aksjer for Aurobindo Pharma Limited (AUROPHARMA)
Antall utestående aksjer per June 2026: 578.14M
Ifølge Aurobindo Pharma Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 578.14M. Ved slutten av March 2024 hadde selskapet 585.94M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Aurobindo Pharma Limited (AUROPHARMA) fra 2004 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 578.14M | -0.81% |
| 2025 | 582.87M | -0.52% |
| 2024 | 585.94M | 0.00% |
| 2023 | 585.94M | -0.01% |
| 2022 | 586.00M | 0.01% |
| 2021 | 585.94M | 0.00% |
| 2020 | 585.94M | 0.01% |
| 2019 | 585.91M | 0.00% |
| 2018 | 585.88M | 0.11% |
| 2017 | 585.22M | 0.16% |
| 2016 | 584.27M | 0.08% |
| 2015 | 583.84M | 0.00% |
| 2014 | 583.84M | 0.23% |
| 2013 | 582.48M | 0.04% |
| 2012 | 582.24M | 1.13% |
| 2011 | 575.74M | 6.32% |
| 2010 | 541.53M | 0.72% |
| 2009 | 537.65M | 0.24% |
| 2008 | 536.39M | 0.63% |
| 2007 | 533.02M | 1.56% |
| 2006 | 524.84M | 3.38% |
| 2005 | 507.70M | 6.06% |
| 2004 | 478.69M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 315.01% |
IN
|
